The current risk assessment score of Prophase Labs Inc is 1.55, ranking 71 out of 78 in the Healthcare Providers & Services industry. The company's beta value is -0.57. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.